The Effect of Standard vs. Shorter Filter Lifespan During Continuous Renal Replacement Therapy

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversität Münster

About this trial

This study aims to investigate shorter vs. standard filter lifespans in critically ill patients receiving continuous renal replacement therapy (CRRT) for acute kidney injury (AKI). The aim of this trial is to reliably implement,scheduled filter changes and to investigate whether shorter filter lifetime is associated with a lower incidence in rate of new infections.

Eligibility criteria

Qualifiers

Adult ≥ 18 years

Critically ill patients with severe AKI consistent with KDIGO stage 3 and an absolute indication for CRRT

Written consent form from the patient or legal representative or authorized representative or emergency inclusion

Disqualifiers

End-stage kidney disease or chronic dialysis dependence

Chronic kidney disease with eGFR<20ml/min/1.73 m²

Prior kidney transplant

Prior renal replacement therapy during the index admission before randomization

Trial design

Treatments tested in this trial

  • time span of filter change

Treatment groups

100 Participants
are divided into 2 treatment groups

Sponsors and collaborators